Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (241-250 of 443) with videos related to

Pageof 45
Sort By:
Journal of Hematology & Oncology|April 2, 2021
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Mohamed Houhou, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Tomasz Czerw, et al.
Haematologica|December 16, 2017
Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and <i>FLT3</i> internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute LeukemiaArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Bone Marrow Transplantation|September 28, 2019
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)Basil Sharrack, Riccardo Saccardi, Tobias Alexander, et al.
Transplantation and Cellular Therapy|October 10, 2023
Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationGiorgia Battipaglia, Myriam Labopin, Stephan Mielke, et al.
Bone Marrow Transplantation|August 8, 2023
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMTJaime Sanz, Myriam Labopin, Thomas Pabst, et al.
Leukemia|August 21, 2019
Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMTNoga Shem-Tov, Christophe Peczynski, Myriam Labopin, et al.
Bone Marrow Transplantation|May 13, 2025
Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMTGiorgia Battipaglia, Myriam Labopin, Aleksandr Kulagin, et al.
Pageof 45

Showing results (241-250 of 443) with videos related to

Sort By:
Pageof 45
Journal of Hematology & Oncology|April 2, 2021
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Mohamed Houhou, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMTSebastian Giebel, Myriam Labopin, Tomasz Czerw, et al.
Haematologica|December 16, 2017
Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and <i>FLT3</i> internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute LeukemiaArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Bone Marrow Transplantation|September 28, 2019
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)Basil Sharrack, Riccardo Saccardi, Tobias Alexander, et al.
Transplantation and Cellular Therapy|October 10, 2023
Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationGiorgia Battipaglia, Myriam Labopin, Stephan Mielke, et al.
Bone Marrow Transplantation|August 8, 2023
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMTJaime Sanz, Myriam Labopin, Thomas Pabst, et al.
Leukemia|August 21, 2019
Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMTNoga Shem-Tov, Christophe Peczynski, Myriam Labopin, et al.
Bone Marrow Transplantation|May 13, 2025
Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMTGiorgia Battipaglia, Myriam Labopin, Aleksandr Kulagin, et al.
Pageof 45